Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer

Anaplastic thyroid cancer (ATC) is the most aggressive form of thyroid cancer, and novel combined therapies are urgently needed to prolong patient survival. No data are currently available on the preclinical activity of the combination of linifanib, a CSF-1R inhibitor, and irinotecan in ATC. The aim...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Cancer Res
Main Authors: Banchi, Marta, Orlandi, Paola, Gentile, Daniela, Alì, Greta, Fini, Elisabetta, Fontanini, Gabriella, Francia, Giulio, Bocci, Guido
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407355/
https://ncbi.nlm.nih.gov/pubmed/32775005
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki